Oil Refineries Announces Financial Results for Third Quarter and Nine M...(5 3266174 ...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007
Date:11/20/2007
5 3,266,174
-------------- --------------
Long-term liabilities
Debentures 974,246 854,799
Loans and liabilities 1,934,173 2,205,647
Long-term derivative instrument 4,280 -
Deferred taxes 539,697 498,352
Liability in respect of financing lease 29,187 29,275
Liability for employee termination benefits,
net 254,204 278,801
_________ _________
3,735,787 3,866,874
-------------- --------------
Total liabilities 7,142,512 7,133,048
-------------- --------------
Shareholders' equity 3,104,784 2,714,677
-------------- --------------
10,247,296 9,847,725
_________ _________
_________ _________
(ii) Reclassified.
Oil Refineries Ltd.
Consolidated Pro-Forma Profit and Loss Statements
In thousands of reported NIS, except per share amounts
Nine month period Three month period Year ended
ended September 30, ended September 30, December 31,
2007 2006 2007 2006 2006
Actual Pro forma Actual Pro forma Pro forma
Unaudited Unaudite
'/>"/>
| SOURCE Oil Refineries Ltd Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
(Date:11/25/2009)....25/PRNewswire/--Formanybusinesses,2009hasbeenapai...fastestgrowingnetworkofexpertphysiciansspecializin...ones has grownthenumberof physiciansinitsnetwork...progresstoaddmorephysician-ownedcenters,includingo...year ,BodyLogicMDhasopened13newbioidenticalhormone...
(Date:11/25/2009)...FirstCall/--ArdeaBiosciences,Inc.(Nasdaq: RDEA )an...chiefexecutiveofficer,willpresentatthePiperJaffray...tailsareasfollows:,PiperJaffray21stAnnualHealthCa...p.m.EasternTime,Location:TheNewYorkPalaceHotel,New...t/ireye/,target=,_blank,title=,http://www.corpora...
(Date:11/24/2009)...ork investment bank KTA Capital,s client Neuren Ph...il convertible note private placement with a U.S. ...arranged by KTA Capital as Neuren,s exclusive plac... New York (PRWEB) November 23, 2009 -- The indepe...quot;KTA Capital") has announced that its cli...
(Date:11/24/2009)...FirstCall/--Sigma-AldrichCorporation(Nasdaq: SIAL ...,December1stat1:45PMGMTinLondon,7:45AMUS/CST.Inter...nternetavailableat http://inve s tor.sig m a ...ccessthisfile. ,, AboutSigma-Aldrich: Sigma-...ny.Itschemicalandbiochemicalproductsandkitsareused...
Breaking Biology Technology:Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2[0] Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate[0] Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference[0] KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals[0] Sigma-Aldrich to Present at the NASDAQ OMX 23rd Investor Program on Tuesday, December 1, 2009
...able in German . , The enzyme DFPase from the ...fficiently detoxify chemical warfare agents such a...ks in 1995. A detailed understanding ,of the mecha...is ,necessary for efforts aiming to improve their ...ity of Frankfurt, the Bundeswehr Institute ,for Ph...
...ril 17 Keystone Symposia on Molecular and Cellula...ogy of RNA Silencing" on April 25, 2009 at the Fai...ia. This will be an opportunity to hear two Nobel ...Fire of Stanford University will deliver a keyno...es in the Small RNA-ome." On Monday morning, April...
... Angela Shen-Hsieh, Founder of Visual I|O has be...dest and largest membership organization for desig...s intelligence software, that lets users throughou...ally with structured and unstructured data for rev...analysis. , New York, NY ...
Other Biology Technology:Structure of enzyme against chemical warfare agents determined 2Nobel Laureates to Speak at Keystone Symposia RNA Silencing Conference 2Angela Shen-Hsieh of Visual I|O Named to Board of Directors of AIGA: Oldest and Largest Membership Organization for Designers 2Angela Shen-Hsieh of Visual I|O Named to Board of Directors of AIGA: Oldest and Largest Membership Organization for Designers 3(Date:11/25/2009)...y assistant professors recently received funding f...nue research beneficial to understanding the envir...topher Blackwood, assistant professor in the Depar...o support two separate research projects. , His ...r Communities and Functions from the Leaf to the L...
(Date:11/24/2009)...tute (LRI) today named 12 new grant recipients for...e innovative work across a broad spectrum of lupus... novelty, and potential to drive scientific discov...plex disease of systemic lupus. , The 2009 grant... across the nation and include interdisciplinary a...
(Date:11/24/2009)...d and flabby arteries from collapsing have been tr... are no longer needed -- once the arteries are str...ctors had no choice but to leave them in place. ,...Department of Biomedical Engineering has developed...drugs where they,re needed, then dissolves. , "O...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A coating for life 2Utah ethicist heads stem cell panel 10048 1Utah ethicist heads stem cell panel 10048 2Utah ethicist heads stem cell panel 10048 3Final 12 Month Clinical Data from 5 000 Patients in Worldwide e HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich 14218 1Final 12 Month Clinical Data from 5 000 Patients in Worldwide e HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich 14218 2Final 12 Month Clinical Data from 5 000 Patients in Worldwide e HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich 14218 3Final 12 Month Clinical Data from 5 000 Patients in Worldwide e HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich 14218 4Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 1Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 2Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 3Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 4Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 5Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 6Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 7Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 8...of a therapeutic cancer vaccine combining the synt... Coley Pharmaceutical), with a peptide antigen wer...igation. The paper shows that the CpG 7909 DNA seq...bility to recognize and destroy cancer cells. The ... of the Ludwig Institute for Cancer Research (LICR...
...ice in field trials in China report higher crop yi...lated health problems, according to a study by res...e University of California, Davis. , Results of t...journal Science. , "This paper studies two of the ...oduction trials, the last step before commercializ...
...tion robbed Elma Phifer of her vision two decades ...eas and reduced the ability of her eyes to soothe ...ame to rely upon family and friends to help her do...sometimes take for granted. Now, twenty years and ... again, thanks to advances in ophthalmology resear...
Other Biology News:Pathogen-Mimicking Vaccine As Strategy For Cancer Therapy 2Genetically modified rice in China benefits farmers' health, study finds 2Genetically modified rice in China benefits farmers' health, study finds 3Genetically modified rice in China benefits farmers' health, study finds 4Artifical cornea lets woman blind 20 years see 2Artifical cornea lets woman blind 20 years see 3Artifical cornea lets woman blind 20 years see 4...e DNA quantitation kit is used to quantitate doubl...esence of RNA or protein. With this kit, DNA is st...d with a VersaFluor or other fluorometer. The kit ...5 micrograms per ml and contains Hoechst 33258, ca...
Pokeweed Mitogen Spleen Cell Conditioned Medium, 25 mL from StemCell Technologies, Inc.
PROTEIN G PLUS AGAROSE from Pierce Biotechnology, Inc.
MagNA Pure LC Instrument from Roche Applied Science
Biology Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |